Clinical Trials · NCT00230594
Desmopressin Response in the Young
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Ferring Pharmaceuticals
- Enrollment
- 132
- Start date
- Jul 2004
- Locations
- 9 sites, Canada
- Primary endpoint
- To evaluate the efficacy of desmopressin administered as a melt tablet compared to placebo in terms of reducing the number of wet nights in children and adolescents with primary nocturnal enuresis.